The study was made possible thanks to a €5.9 million ($8.1 million) award from the European Commission. A total of 3,000 patients will be involved in the trial. They will have the chance to get more years of life if stem cells from the patient's own bone marrow will produce the expected effect. The operation itself has something spectacular: the stem cells are injected into the patient's heart within 5 days of suffering a heart attack .The estimated rate of success , in other words the survival rates should be by 25%. "The BAMI study is the biggest and most comprehensive trial of its kind in the world," adds trial chief co-ordinator Prof. Anthony Mathur. "It has taken 2 years to get to the point where we are ready to accept patients, but we have now reached that stage and we are all very excited. " A powerful partnership of European doctors and scientists will be involved in this study, with scientists from 19 partners medical institutes across France, Germany, Italy, Finland, Denmark, Spain, Belgium, Poland, the Czech Republic and the UK.